肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访

2020-06-24 意大利肿瘤医学协会 Cancers (Basel) . 2020 Jun 24;12(6):E1681.

胰腺导管外分泌腺癌

2020年6月，意大利肿瘤医学协会(AIOM)发布了胰腺导管外分泌腺癌的诊断，治疗和随访指南。胰腺导管癌的5年预期寿命约为5%，本文主要总结了胰腺导管腺癌的诊断，治疗和随访的相关内容以指导临床实践。

中文标题：

2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访

英文标题：

Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)

发布机构：

意大利肿瘤医学协会

发布日期：

2020-06-24

简要介绍：

2020年6月，意大利肿瘤医学协会(AIOM)发布了胰腺导管外分泌腺癌的诊断，治疗和随访指南。胰腺导管癌的5年预期寿命约为5%，本文主要总结了胰腺导管腺癌的诊断，治疗和随访的相关内容以指导临床实践。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a8fb91c00193a925, title=2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访, enTitle=Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM), guiderFrom=Cancers (Basel) . 2020 Jun 24;12(6):E1681., authorId=0, author=, summary=2020年6月，意大利肿瘤医学协会(AIOM)发布了胰腺导管外分泌腺癌的诊断，治疗和随访指南。胰腺导管癌的5年预期寿命约为5%，本文主要总结了胰腺导管腺癌的诊断，治疗和随访的相关内容以指导临床实践。, cover=https://img.medsci.cn/2020714/1594660371550_2020535.jpg, journalId=0, articlesId=null, associationId=1673, associationName=意大利肿瘤医学协会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月，意大利肿瘤医学协会(AIOM)发布了胰腺导管外分泌腺癌的诊断，治疗和随访指南。胰腺导管癌的5年预期寿命约为5%，本文主要总结了胰腺导管腺癌的诊断，治疗和随访的相关内容以指导临床实践。</p> </div> </div> </div>, tagList=[TagDto(tagId=105000, tagName=胰腺导管外分泌腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=718, guiderKeyword=胰腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3094, appHits=75, showAppHits=0, pcHits=422, showPcHits=3019, likes=1, shares=1, comments=5, approvalStatus=1, publishedTime=Tue Jul 14 01:17:13 CST 2020, publishedTimeString=2020-06-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 14 01:12:57 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 23:07:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访.pdf)])
2020 AIOM临床实践指南：胰腺导管外分泌腺癌的诊断，治疗和随访.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=881760, encodeId=4671881e6093, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI2hkBCWc8nbk9d3KLVDLqfAicgL6FzfwHk4fu0TTDEgAvTViabYPQSXSHicxibmFsoRX0hRkL05zuhpg/132, createdBy=c9155324105, createdName=尚方大帝, createdTime=Tue Sep 01 13:45:31 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812864, encodeId=6b6581286439, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/ibz2HQeVQM6BfkEWaWQnF5wn92jyroX7o8zcXA5JRbIfDHk4I39OsU1PhZKnvPhEN6sk3J8TenMibxGL68HMfTew/132, createdBy=92555321953, createdName=anne1023, createdTime=Tue Aug 25 00:03:25 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805205, encodeId=4f52805205e2, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Thu Jul 30 15:47:28 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-09-01 尚方大帝

    优秀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=881760, encodeId=4671881e6093, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI2hkBCWc8nbk9d3KLVDLqfAicgL6FzfwHk4fu0TTDEgAvTViabYPQSXSHicxibmFsoRX0hRkL05zuhpg/132, createdBy=c9155324105, createdName=尚方大帝, createdTime=Tue Sep 01 13:45:31 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812864, encodeId=6b6581286439, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/ibz2HQeVQM6BfkEWaWQnF5wn92jyroX7o8zcXA5JRbIfDHk4I39OsU1PhZKnvPhEN6sk3J8TenMibxGL68HMfTew/132, createdBy=92555321953, createdName=anne1023, createdTime=Tue Aug 25 00:03:25 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805205, encodeId=4f52805205e2, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Thu Jul 30 15:47:28 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-08-25 anne1023

    好东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=881760, encodeId=4671881e6093, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI2hkBCWc8nbk9d3KLVDLqfAicgL6FzfwHk4fu0TTDEgAvTViabYPQSXSHicxibmFsoRX0hRkL05zuhpg/132, createdBy=c9155324105, createdName=尚方大帝, createdTime=Tue Sep 01 13:45:31 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812864, encodeId=6b6581286439, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/ibz2HQeVQM6BfkEWaWQnF5wn92jyroX7o8zcXA5JRbIfDHk4I39OsU1PhZKnvPhEN6sk3J8TenMibxGL68HMfTew/132, createdBy=92555321953, createdName=anne1023, createdTime=Tue Aug 25 00:03:25 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805205, encodeId=4f52805205e2, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Thu Jul 30 15:47:28 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-07-30 1487b89em13暂无昵称

    👍👍👍

    0

拓展阅读

2010ESMO临床实践指南：胰腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

胰腺癌诊疗规范（2011年版）

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-10-14

2012 胰腺癌经动脉灌注化疗指南(草案)

中华医学会放射学分会介入学组 · 2012-05-30

2012 ESMO临床实践指南：胰腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2013 胰腺癌多学科综合治疗协作组专家共识

中华医学会肿瘤学分会 · 2013-05-01

胰腺癌综合诊治中国专家共识(2013年）（征求意见稿）

CSCO胰腺癌专家委员会 · 2013-09-01